Product Information
QC MUCUS RLF DM 20-400 MG CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0795 per EA under NDC 83324019550. Its NADAC has been published 81 times since Feb 5, 2025.
The Low Outlier badge above means this manufacturer's average price in the Dextromethorphan Hydrobromide / Guaifenesin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20; 400 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324019550
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/14/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MUCUS RLF DM 20-400 MG CPLT has been published 81 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0795 per EA |
|---|---|
| All-time high | $0.0798 (Mar 11, 2026) |
| All-time low | $0.0771 (Jun 18, 2025) |
| 52-week high | $0.0798 |
| 52-week low | $0.0779 |
| Median price | $0.0786 |
| Average price | $0.0785 |
| Largest weekly change | +2.0% (Feb 18, 2026) |
| Weeks tracked | 81 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QC MUCUS RLF DM 20-400 MG CPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC MUCUS RLF DM 20-400 MG CPLT, manufactured by Chain Drug Marketing Association, is $0.0795 per EA (NDC 83324019550), effective Aug 19, 2026.
How has the price of QC MUCUS RLF DM 20-400 MG CPLT changed over time?
Over the history we have for it, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has held within roughly two percent of its current level. It has been tracked across 81 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC MUCUS RLF DM 20-400 MG CPLT?
Since Feb 5, 2025, the NADAC for QC MUCUS RLF DM 20-400 MG CPLT has ranged from a low of $0.0771 (Jun 18, 2025) to a high of $0.0798 (Mar 11, 2026), with a median of $0.0786 per EA.
Are there cheaper alternatives to QC MUCUS RLF DM 20-400 MG CPLT?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 4% below QC MUCUS RLF DM 20-400 MG CPLT.
Who manufactures QC MUCUS RLF DM 20-400 MG CPLT?
QC MUCUS RLF DM 20-400 MG CPLT (NDC 83324019550) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.